Pfizer Stock Price Target and Analyst Ratings (NYSE:PFE)

Analyst Price Target for PFE

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$40.07

▲ +9.04% Upside Potential

This price target is based on 14 analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $40.07, with a high forecast of $53.00 and a low forecast of $24.00. The average price target represents a 9.04% upside from the last price of $36.75.

Hold

The current consensus among 14 contributing investment analysts is to hold stock in Pfizer. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
3 buy ratings
16 hold ratings
0 sell ratings

Ratings as of

7/24/2019

0 strong buy ratings
2 buy ratings
13 hold ratings
0 sell ratings

Ratings as of

10/22/2019

0 strong buy ratings
2 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

1/20/2020

0 strong buy ratings
3 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

4/19/2020

0 strong buy ratings
3 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

7/18/2020

0 strong buy ratings
3 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

10/16/2020

0 strong buy ratings
4 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

12/15/2020

0 strong buy ratings
4 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

1/14/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
1/8/2021	The Goldman Sachs Group	Set Price Target	Neutral	$40.00	Low	i
1/4/2021	Royal Bank of Canada	Set Price Target	Neutral	$42.00	N/A	i
12/29/2020	Royal Bank of Canada	Reiterated Rating	Neutral	$42.00	N/A	i
12/16/2020	Royal Bank of Canada	Downgrade	Outperform ➝ Sector Perform	$43.00 ➝ $42.00	N/A	i
12/11/2020	The Goldman Sachs Group	Set Price Target	Neutral	$40.00	Low	i
12/4/2020	Barclays	Boost Price Target	Equal Weight	$35.00 ➝ $37.00	Low	i
12/2/2020	Barclays	Set Price Target	Neutral	$35.00	Medium	i
12/2/2020	Royal Bank of Canada	Set Price Target	Buy	$43.00	Low	i
12/2/2020	The Goldman Sachs Group	Set Price Target	Neutral	$40.00	Low	i
11/19/2020	The Goldman Sachs Group	Initiated Coverage	Neutral	$40.00	Medium	i
11/10/2020	Sanford C. Bernstein	Initiated Coverage	Market Perform	$42.00	High	i
11/10/2020	Mizuho	Boost Price Target	Buy	$43.00 ➝ $44.00	High	i Rating by Vamil Divan at Mizuho
11/9/2020	Barclays	Reiterated Rating	Neutral	$35.00	High	i
11/9/2020	JPMorgan Chase & Co.	Set Price Target	Neutral	$36.00	High	i
10/28/2020	SVB Leerink	Boost Price Target	Market Perform	$42.00 ➝ $43.00	High	i Rating by G. Porges at SVB Leerink LLC
10/23/2020	Truist	Initiated Coverage	Buy	$42.00	Low	i
10/16/2020	Royal Bank of Canada	Set Price Target	Buy	$43.00	Low	i
10/12/2020	Atlantic Securities	Downgrade	Overweight ➝ Neutral	$44.00 ➝ $39.00	Low	i
9/29/2020	Berenberg Bank	Initiated Coverage	Hold	$38.00	Low	i
9/15/2020	Mizuho	Reiterated Rating	Buy	$43.00	Low	i Rating by Vamil Divan at Mizuho
9/9/2020	Royal Bank of Canada	Set Price Target	Buy	$43.00	Low	i
7/30/2020	Morgan Stanley	Boost Price Target	Equal Weight	$36.00 ➝ $42.00	Low	i Rating by David Risinger at Morgan Stanley
7/29/2020	UBS Group	Boost Price Target	Neutral	$37.00 ➝ $39.00	Low	i
7/29/2020	SVB Leerink	Boost Price Target	Market Perform	$39.00 ➝ $42.00	Low	i Rating by G. Porges at SVB Leerink LLC
7/28/2020	Mizuho	Reiterated Rating	Positive ➝ Buy	$38.00	Low	i Rating by Vamil Divan at Mizuho
7/21/2020	Morgan Stanley	Reiterated Rating	Hold	$36.00	High	i Rating by David Risinger at Morgan Stanley
7/20/2020	Royal Bank of Canada	Reiterated Rating	Buy	$43.00	High	i
6/29/2020	Mizuho	Initiated Coverage	Buy	$38.00	Low	i Rating by Vamil Divan at Mizuho
6/26/2020	Piper Sandler	Boost Price Target		$18.50 ➝ $24.00	Medium	i
6/16/2020	SVB Leerink	Initiated Coverage	Market Perform	$40.00	Low	i Rating by G. Porges at SVB Leerink LLC
6/1/2020	Barclays	Lower Price Target		$37.00 ➝ $35.00	Medium	i
6/1/2020	JPMorgan Chase & Co.	Lower Price Target	Neutral	$37.00 ➝ $36.00	High	i
5/18/2020	Mizuho	Reiterated Rating	Buy	$42.00	Low	i Rating by Vamil Divan at Mizuho
4/29/2020	Barclays	Boost Price Target	Equal Weight	$36.00 ➝ $37.00	Low	i
4/27/2020	Royal Bank of Canada	Reiterated Rating	Buy	$44.00	Medium	i
4/26/2020	Mizuho	Reiterated Rating	Buy	$42.00	High	i Rating by Vamil Divan at Mizuho
4/2/2020	Morgan Stanley	Lower Price Target	Equal Weight	$43.00 ➝ $36.00	Medium	i
3/27/2020	Royal Bank of Canada	Lower Price Target	Outperform	$46.00 ➝ $44.00	Low	i
3/19/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$53.00	High	i Rating by Louise Chen at Cantor Fitzgerald
3/18/2020	Mizuho	Reiterated Rating	Buy	$42.00	High	i Rating by Vamil Divan at Mizuho
2/27/2020	Standpoint Research	Upgrade	Hold ➝ Buy		High	i
2/27/2020	Barclays	Initiated Coverage	Equal Weight	$36.00	Medium	i
2/5/2020	Mizuho	Initiated Coverage	Buy	$42.00	Low	i
1/29/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$53.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
1/28/2020	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$37.00	Low	i
1/6/2020	Royal Bank of Canada	Initiated Coverage	Outperform	$46.00	Medium	i
11/6/2019	Credit Suisse Group	Reiterated Rating	Hold	$41.30	Low	i
10/29/2019	JPMorgan Chase & Co.	Reiterated Rating	Neutral		High	i Rating by Chris Schott at JPMorgan Chase & Co.
10/16/2019	Bank of America	Initiated Coverage	Neutral	$37.00	Low	i
9/19/2019	JPMorgan Chase & Co.	Boost Price Target	Neutral	$37.00 ➝ $46.00	Low	i Rating by Chris Schott at JPMorgan Chase & Co.
8/28/2019	DZ Bank	Upgrade	Sell ➝ Hold	$36.00	Medium	i
8/27/2019	Morgan Stanley	Lower Price Target	Equal Weight	$40.00 ➝ $38.00	High	i
8/27/2019	DZ Bank	Reiterated Rating	Hold ➝ Neutral		Medium	i
8/12/2019	Credit Suisse Group	Reiterated Rating	Hold ➝ Neutral		High	i
8/5/2019	UBS Group	Reiterated Rating	Neutral	$43.00	High	i
7/30/2019	Bank of America	Downgrade	Buy ➝ Neutral		High	i
7/30/2019	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$48.00 ➝ $40.00	High	i
7/29/2019	JPMorgan Chase & Co.	Set Price Target	Neutral	$46.00	High	i Rating by Chris Schott at JPMorgan Chase & Co.
7/23/2019	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$46.00	Low	i Rating by Chris Schott at JPMorgan Chase & Co.
7/15/2019	Credit Suisse Group	Initiated Coverage	Hold	$47.00	Low	i
6/17/2019	Credit Suisse Group	Reiterated Rating	Buy	$48.00	Low	i
6/17/2019	The Goldman Sachs Group	Reiterated Rating	Buy	$49.00	Low	i
6/17/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold	$46.00	Low	i
6/4/2019	Morgan Stanley	Initiated Coverage	Overweight ➝ Overweight	$48.00	Low	i
5/28/2019	The Goldman Sachs Group	Initiated Coverage	Conviction-Buy		Low	i
5/9/2019	Barclays	Reiterated Rating	Hold	$41.00	Low	i
5/6/2019	Credit Suisse Group	Reiterated Rating	Buy	$48.00	Medium	i Rating by Vamil Divan at Credit Suisse Group AG
4/30/2019	JPMorgan Chase & Co.	Set Price Target	Neutral	$46.00	Low	i Rating by Chris Schott at JPMorgan Chase & Co.
4/19/2019	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$46.00	N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
4/1/2019	Bank of America	Boost Price Target	Buy ➝ Buy	$45.00 ➝ $48.00	Low	i
2/20/2019	Citigroup	Reiterated Rating	Sell ➝ Neutral	$41.00	Medium	i Rating by Andrew Baum at Citigroup Inc.
2/19/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$53.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
1/31/2019	Argus	Upgrade	Hold ➝ Buy	$55.00	Medium	i
1/31/2019	Credit Suisse Group	Upgrade	Neutral ➝ Outperform		Medium	i Rating by Vamil Divan at Credit Suisse Group AG
1/28/2019	Credit Suisse Group	Reiterated Rating	Neutral	$45.00	High	i Rating by Vamil Divan at Credit Suisse Group AG
1/23/2019	UBS Group	Downgrade	Buy ➝ Neutral		Low	i
1/1/2019	Credit Suisse Group	Set Price Target	Neutral	$45.00	Medium	i Rating by Vamil Divan at Credit Suisse Group AG
12/30/2018	Cantor Fitzgerald	Set Price Target	Buy	$53.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
12/26/2018	Credit Suisse Group	Set Price Target	Neutral	$45.00	High	i Rating by Vamil Divan at Credit Suisse Group AG
12/20/2018	Credit Suisse Group	Reiterated Rating	Neutral	$45.00	Low	i Rating by Vamil Divan at Credit Suisse Group AG
12/13/2018	Credit Suisse Group	Set Price Target	Hold	$45.00	Medium	i Rating by Vamil Divan at Credit Suisse Group AG
12/11/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$53.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
12/11/2018	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$46.00	Low	i Rating by Chris Schott at JPMorgan Chase & Co.
11/27/2018	Atlantic Securities	Reiterated Rating	Buy	$54.00	Medium	i
11/26/2018	Credit Suisse Group	Set Price Target	Hold	$42.00	Medium	i Rating by Vamil Divan at Credit Suisse Group AG
11/19/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$53.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
11/8/2018	Cantor Fitzgerald	Set Price Target	Buy	$53.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
11/6/2018	Citigroup	Boost Price Target	Sell ➝ Sell	$34.00 ➝ $37.00	Medium	i
11/1/2018	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$47.00 ➝ $46.00	Medium	i
11/1/2018	Societe Generale	Set Price Target	Hold	$43.00	Medium	i Rating by Florent Cespedes at Societe Generale
10/30/2018	Credit Suisse Group	Reiterated Rating	Neutral ➝ Neutral	$40.00	Low	i Rating by Vamil Divan at Credit Suisse Group AG
10/30/2018	The Goldman Sachs Group	Reiterated Rating	Neutral	$45.00	Low	i
10/30/2018	JPMorgan Chase & Co.	Reiterated Rating	Buy		Low	i Rating by Chris Schott at JPMorgan Chase & Co.
10/23/2018	Wolfe Research	Initiated Coverage	Market Perform		Low	i
10/19/2018	Barclays	Set Price Target	Neutral	$40.00	Low	i
10/17/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$53.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
10/14/2018	Credit Suisse Group	Set Price Target	Hold	$40.00	Low	i Rating by Vamil Divan at Credit Suisse Group AG
10/9/2018	Morningstar	Set Price Target	Neutral	$46.00	Low	i
10/4/2018	Cantor Fitzgerald	Set Price Target	Buy	$45.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
10/4/2018	Independent Research	Set Price Target	Neutral	$48.00	Low	i
10/1/2018	JPMorgan Chase & Co.	Set Price Target	Buy	$46.00	Low	i Rating by Chris Schott at JPMorgan Chase & Co.
9/27/2018	Morningstar	Set Price Target	Buy	$46.00	Low	i
9/26/2018	Barclays	Reiterated Rating	Neutral	$40.00	Low	i
9/26/2018	Cantor Fitzgerald	Set Price Target	Buy	$45.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
9/13/2018	Morgan Stanley	Set Price Target	Buy	$45.00	Medium	i Rating by David Risinger at Morgan Stanley
9/13/2018	Cantor Fitzgerald	Set Price Target	Buy	$45.00	Medium	i Rating by Louise Chen at Cantor Fitzgerald
9/10/2018	JPMorgan Chase & Co.	Set Price Target	Buy	$42.00	Medium	i
9/7/2018	BMO Capital Markets	Boost Price Target	Outperform	$47.00	Medium	i Rating by Alex Arfaei at BMO Capital Markets
9/6/2018	Credit Suisse Group	Set Price Target	Hold	$40.00	Low	i Rating by Vamil Divan at Credit Suisse Group AG
9/6/2018	Morgan Stanley	Set Price Target	Buy	$45.00	Low	i Rating by David Risinger at Morgan Stanley
8/29/2018	Barclays	Set Price Target	Neutral	$40.00	Low	i
8/29/2018	Morgan Stanley	Set Price Target	Buy	$45.00	Low	i Rating by David Risinger at Morgan Stanley
8/28/2018	Credit Suisse Group	Set Price Target	Neutral	$40.00	Low	i Rating by Vamil Divan at Credit Suisse Group AG
8/28/2018	The Goldman Sachs Group	Reiterated Rating	Neutral	$45.00	Low	i
8/28/2018	Morningstar	Set Price Target	Buy	$46.00	Low	i
8/27/2018	BMO Capital Markets	Reiterated Rating	Buy	$44.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
8/27/2018	Cantor Fitzgerald	Set Price Target	Buy	$45.00	High	i Rating by Louise Chen at Cantor Fitzgerald
8/23/2018	JPMorgan Chase & Co.	Reiterated Rating	Buy	$42.00	Low	i
8/23/2018	Barclays	Boost Price Target	Equal Weight ➝ Neutral	$38.00 ➝ $40.00	Low	i
8/23/2018	Morgan Stanley	Set Price Target	Overweight ➝ Buy	$43.00 ➝ $45.00	Low	i Rating by David Risinger at Morgan Stanley
8/21/2018	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$42.00 ➝ $45.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
8/13/2018	Cantor Fitzgerald	Set Price Target	Buy	$45.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
8/10/2018	SunTrust Banks	Boost Price Target	Hold	$41.00	Low	i
8/8/2018	Morningstar	Set Price Target	Buy	$45.00	Low	i
8/1/2018	Bank of America	Boost Price Target	Buy ➝ Buy	$42.00 ➝ $43.00	Low	i
8/1/2018	The Goldman Sachs Group	Reiterated Rating	Neutral	$42.00	Low	i
8/1/2018	BMO Capital Markets	Boost Price Target	Outperform ➝ Outperform	$42.00 ➝ $44.00	Medium	i Rating by Alex Arfaei at BMO Capital Markets
8/1/2018	Credit Suisse Group	Boost Price Target	Neutral ➝ Neutral	$39.00 ➝ $40.00	Medium	i Rating by Vamil Divan at Credit Suisse Group AG
7/31/2018	Jefferies Financial Group	Set Price Target	Neutral	$39.00	High	i Rating by Ian Hilliker at Jefferies Financial Group Inc.
7/31/2018	JPMorgan Chase & Co.	Reiterated Rating	Buy		High	i
7/31/2018	Credit Suisse Group	Set Price Target	Hold	$39.00	High	i
7/31/2018	Cantor Fitzgerald	Set Price Target	Buy	$45.00	High	i Rating by Louise Chen at Cantor Fitzgerald
7/19/2018	BMO Capital Markets	Reiterated Rating	Buy	$42.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
7/18/2018	JPMorgan Chase & Co.	Reiterated Rating	$37.66		Medium	i
7/18/2018	Cantor Fitzgerald	Set Price Target	Buy	$45.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
7/15/2018	Jefferies Financial Group	Set Price Target	Hold	$39.00	Low	i Rating by Ian Hilliker at Jefferies Financial Group Inc.
7/12/2018	Credit Suisse Group	Set Price Target	Neutral	$39.00	Low	i
7/11/2018	Cantor Fitzgerald	Set Price Target	Buy	$45.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
7/11/2018	JPMorgan Chase & Co.	Reiterated Rating	Buy	$42.00	Low	i
7/9/2018	Jefferies Financial Group	Reiterated Rating	Neutral	$39.00	Medium	i Rating by Ian Hilliker at Jefferies Financial Group Inc.
6/13/2018	Cantor Fitzgerald	Set Price Target	Buy	$45.00	Low	i Rating by L. Chen at Cantor Fitzgerald
6/11/2018	Morgan Stanley	Reiterated Rating	Buy	$43.00	Low	i
6/11/2018	Credit Suisse Group	Set Price Target	Neutral	$39.00	Low	i
6/7/2018	Cantor Fitzgerald	Initiated Coverage	Overweight	$45.00	Low	i Rating by L. Chen at Cantor Fitzgerald
5/30/2018	Societe Generale	Reiterated Rating	Neutral	$39.00	Low	i
5/18/2018	Credit Suisse Group	Reiterated Rating	Neutral	$39.00	Low	i
5/14/2018	Jefferies Financial Group	Reiterated Rating	Neutral	$39.00	Low	i Rating by Ian Hilliker at Jefferies Financial Group Inc.
5/8/2018	JPMorgan Chase & Co.	Set Price Target	Buy	$42.00	Low	i
5/3/2018	DZ Bank	Reiterated Rating	Sell		Low	i
5/2/2018	Morningstar	Set Price Target	Buy	$43.50	Low	i
5/2/2018	BMO Capital Markets	Lower Price Target	Outperform ➝ Outperform	$43.00 ➝ $42.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
5/2/2018	JPMorgan Chase & Co.	Reiterated Rating	Buy	$42.00	Medium	i
4/13/2018	Jefferies Financial Group	Set Price Target	Hold	$38.00	Low	i Rating by Ian Hilliker at Jefferies Financial Group Inc.
4/12/2018	Citigroup	Reiterated Rating	Sell		Medium	i Rating by Andrew Baum at Citigroup Inc.
4/11/2018	Berenberg Bank	Reiterated Rating	Neutral	$37.00	Low	i
4/5/2018	Barclays	Downgrade	Overweight ➝ Equal Weight	$41.00 ➝ $38.00	Medium	i
4/2/2018	BMO Capital Markets	Set Price Target	Buy	$43.00	Medium	i Rating by Alex Arfaei at BMO Capital Markets
3/6/2018	BMO Capital Markets	Set Price Target	Buy	$43.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
2/26/2018	Jefferies Financial Group	Set Price Target	Hold	$39.00	Low	i Rating by Ian Hilliker at Jefferies Financial Group Inc.
2/15/2018	BMO Capital Markets	Set Price Target	Buy	$43.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
2/5/2018	BMO Capital Markets	Set Price Target	Buy	$43.00	High	i Rating by Alex Arfaei at BMO Capital Markets
1/31/2018	Barclays	Boost Price Target	Overweight ➝ Overweight	$38.00 ➝ $41.00	Medium	i
1/31/2018	Credit Suisse Group	Boost Price Target	Neutral ➝ Neutral	$37.00 ➝ $39.00	Medium	i
1/31/2018	SVB Leerink	Boost Price Target	Market Perform ➝ Market Perform	$35.00 ➝ $38.00	Medium	i
1/31/2018	UBS Group	Set Price Target	Buy	$42.00	Medium	i Rating by Marc Goodman at UBS Group AG
1/31/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Buy	$41.00 ➝ $43.00	Medium	i
1/31/2018	Societe Generale	Set Price Target	Neutral	$40.00	Medium	i
1/30/2018	The Goldman Sachs Group	Set Price Target	Neutral	$36.00	High	i
1/30/2018	Morningstar	Set Price Target	Neutral	$38.00	High	i
1/30/2018	Bank of America	Set Price Target	Buy	$40.00	Medium	i Rating by Jason Gerberry at Bank of America Co.
1/30/2018	JPMorgan Chase & Co.	Reiterated Rating	Buy		Low	i
1/30/2018	Sanford C. Bernstein	Set Price Target	Buy	$43.00	Low	i
1/30/2018	Berenberg Bank	Set Price Target	Neutral	$36.00	Low	i
1/30/2018	BMO Capital Markets	Set Price Target	Buy	$39.00	High	i Rating by Alex Arfaei at BMO Capital Markets
1/29/2018	SunTrust Banks	Reiterated Rating	Hold ➝ Hold	$33.00 ➝ $40.00	Low	i
1/24/2018	BMO Capital Markets	Set Price Target	Buy	$39.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
1/16/2018	Jefferies Financial Group	Set Price Target	Neutral	$40.00	Low	i
1/8/2018	BMO Capital Markets	Set Price Target	Buy	$39.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
1/5/2018	Morgan Stanley	Set Price Target	Buy	$41.00	Low	i
1/2/2018	Nord/LB	Reiterated Rating	Neutral		Low	i
12/27/2017	Nord/LB	Reiterated Rating	Neutral		Low	i
12/15/2017	BMO Capital Markets	Set Price Target	Buy	$39.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
12/8/2017	BMO Capital Markets	Set Price Target	Buy	$39.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
12/6/2017	UBS Group	Set Price Target	Buy	$40.00	Low	i Rating by Marc Goodman at UBS Group AG
12/6/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$38.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/25/2017	BMO Capital Markets	Set Price Target	Buy	$39.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
11/16/2017	Jefferies Financial Group	Set Price Target	Neutral	$39.00	N/A	i
11/10/2017	BMO Capital Markets	Reiterated Rating	Buy	$39.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
11/1/2017	JPMorgan Chase & Co.	Set Price Target	Buy	$39.00	N/A	i
11/1/2017	Jefferies Financial Group	Set Price Target	Neutral	$39.00	N/A	i
11/1/2017	The Goldman Sachs Group	Set Price Target	Neutral	$36.00	N/A	i
11/1/2017	UBS Group	Set Price Target	Buy	$38.00	N/A	i Rating by Marc Goodman at UBS Group AG
10/31/2017	Berenberg Bank	Set Price Target	Neutral	$36.00	N/A	i
10/31/2017	BMO Capital Markets	Set Price Target	Buy	$39.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
10/26/2017	Jefferies Financial Group	Set Price Target	Neutral	$39.00	N/A	i
10/19/2017	BMO Capital Markets	Reiterated Rating	Buy	$37.00 ➝ $39.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
10/16/2017	Jefferies Financial Group	Set Price Target	Neutral	$38.00	N/A	i
10/11/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$38.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
10/11/2017	Barclays	Set Price Target	Buy	$38.00	N/A	i
10/10/2017	BMO Capital Markets	Set Price Target	Buy	$37.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
9/20/2017	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$35.00 ➝ $39.00	Low	i
9/19/2017	Sanford C. Bernstein	Set Price Target	Buy	$39.00	Low	i
9/18/2017	Jefferies Financial Group	Set Price Target	Neutral	$37.00	Low	i
9/14/2017	BMO Capital Markets	Reiterated Rating	Buy	$37.00	High	i Rating by Alex Arfaei at BMO Capital Markets
9/6/2017	BMO Capital Markets	Reiterated Rating	Buy	$37.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
8/24/2017	Jefferies Financial Group	Set Price Target	Neutral	$35.00	Low	i
8/18/2017	Jefferies Financial Group	Reiterated Rating	Hold	$35.00	Low	i
8/15/2017	Berenberg Bank	Reiterated Rating	Hold	$39.00 ➝ $36.00	Low	i
8/14/2017	Cowen	Set Price Target	Buy	$43.00	Low	i Rating by Steve Scala at Cowen Inc
8/2/2017	Jefferies Financial Group	Set Price Target	Neutral	$35.00	Low	i
8/2/2017	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$33.00 ➝ $37.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
8/1/2017	Berenberg Bank	Set Price Target	Neutral	$39.00	Low	i
7/31/2017	UBS Group	Reiterated Rating	Buy	$38.00	Medium	i
7/20/2017	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$38.00 ➝ $36.00	Low	i
7/17/2017	Sanford C. Bernstein	Set Price Target	Buy	$39.00	Low	i
7/14/2017	Jefferies Financial Group	Reiterated Rating	Hold	$34.00 ➝ $35.00	Low	i
7/10/2017	Cowen	Set Price Target	Buy	$43.00	Low	i Rating by Steve Scala at Cowen Inc
6/16/2017	Jefferies Financial Group	Reiterated Rating	Neutral	$34.00	Low	i
6/12/2017	Morgan Stanley	Reiterated Rating	Neutral	$38.00 ➝ $35.00	Low	i
5/16/2017	Citigroup	Downgrade	Neutral ➝ Sell	$38.00 ➝ $31.00	Low	i
5/3/2017	Barclays	Reiterated Rating	Buy	$38.00	Low	i
5/3/2017	Sanford C. Bernstein	Reiterated Rating	Buy	$37.00	Low	i
4/27/2017	BMO Capital Markets	Reiterated Rating	Hold	$33.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
4/24/2017	Sanford C. Bernstein	Reiterated Rating	Buy	$35.00	Low	i
4/13/2017	Jefferies Financial Group	Reiterated Rating	Neutral	$34.00 ➝ $35.00	Low	i
4/6/2017	Morgan Stanley	Reiterated Rating	Neutral	$38.00	Low	i
3/24/2017	Sanford C. Bernstein	Reiterated Rating	Buy	$35.00	Low	i
3/23/2017	Societe Generale	Reiterated Rating	Neutral	$36.00	Low	i
3/21/2017	BMO Capital Markets	Reiterated Rating	Hold	$33.00	Low	i Rating by Alex Arfaei at BMO Capital Markets
3/16/2017	Barclays	Set Price Target	Buy	$38.00	Low	i
3/14/2017	UBS Group	Reiterated Rating	Buy	$38.00	N/A	i Rating by Marc Goodman at UBS Group AG
3/13/2017	Sanford C. Bernstein	Set Price Target	Buy	$35.00	Low	i
3/13/2017	Credit Suisse Group	Set Price Target	Buy	$38.00	Low	i
3/9/2017	Jefferies Financial Group	Set Price Target	Neutral	$34.00	Low	i
2/17/2017	Jefferies Financial Group	Set Price Target	Neutral	$34.00	N/A	i
2/17/2017	Berenberg Bank	Set Price Target	Neutral	$39.00	N/A	i
2/16/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$40.00	N/A	i
2/2/2017	Morningstar	Reiterated Rating	Buy		N/A	i
2/1/2017	Atlantic Securities	Set Price Target	Buy	$37.00	N/A	i
1/30/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$33.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
1/24/2017	Sanford C. Bernstein	Set Price Target	Buy	$35.00	N/A	i
1/21/2017	Piper Jaffray Companies	Set Price Target	Buy	$53.00	N/A	i Rating by Richard Purkiss at Piper Jaffray Companies
1/19/2017	Jefferies Financial Group	Reiterated Rating	Hold	$30.00	N/A	i
1/18/2017	The Goldman Sachs Group	Set Price Target	Neutral	$36.00	N/A	i
12/20/2016	Credit Suisse Group	Reiterated Rating	Buy	$38.00	N/A	i
12/19/2016	Jefferies Financial Group	Reiterated Rating	Hold	$30.00	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
12/7/2016	Sanford C. Bernstein	Reiterated Rating	Overweight		N/A	i
12/2/2016	Guggenheim	Initiated Coverage	Neutral		N/A	i
11/30/2016	BMO Capital Markets	Set Price Target	Hold	$33.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
11/29/2016	Barclays	Upgrade	Equal Weight ➝ Overweight	$38.00	N/A	i
11/11/2016	Jefferies Financial Group	Set Price Target	Neutral	$34.00	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
11/7/2016	Bank of America	Reiterated Rating	Buy	$40.00 ➝ $36.00	N/A	i Rating by colin bristow at Bank of America Co.
11/3/2016	Atlantic Securities	Set Price Target	Buy	$35.00	N/A	i
11/2/2016	Argus	Downgrade	Buy ➝ Hold		N/A	i Rating by jacob kilstein at Argus
11/2/2016	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$40.00 ➝ $33.00	N/A	i
11/1/2016	Berenberg Bank	Set Price Target	Neutral	$38.00	N/A	i Rating by Alistair Campbell at Berenberg Bank
11/1/2016	Sanford C. Bernstein	Set Price Target	Buy	$36.00	N/A	i
10/19/2016	Sanford C. Bernstein	Set Price Target	Buy	$36.00	N/A	i
10/18/2016	BMO Capital Markets	Reiterated Rating	Outperform	$40.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
10/13/2016	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$39.00 ➝ $36.00	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
10/4/2016	Argus	Reiterated Rating	Buy	$39.00	N/A	i Rating by jacob kilstein at Argus
9/30/2016	UBS Group	Set Price Target	Buy	$38.00	N/A	i Rating by Steven Milunovich at UBS Group AG
9/27/2016	Bank of America	Reiterated Rating	Buy	$40.00	N/A	i Rating by colin bristow at Bank of America Co.
9/26/2016	Sanford C. Bernstein	Reiterated Rating	Outperform		N/A	i Rating by Tim Anderson at Sanford C. Bernstein
9/13/2016	Jefferies Financial Group	Lower Price Target	Buy	$40.00 ➝ $39.00	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
9/7/2016	UBS Group	Reiterated Rating	Buy		N/A	i Rating by Steven Milunovich at UBS Group AG
8/28/2016	Argus	Reiterated Rating	Buy	$39.00	N/A	i Rating by jacob kilstein at Argus
8/25/2016	Jefferies Financial Group	Set Price Target	Buy	$40.00	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
8/23/2016	Piper Jaffray Companies	Set Price Target	Buy	$54.00	N/A	i Rating by richard purkiss at Piper Jaffray Companies
8/23/2016	BMO Capital Markets	Reiterated Rating	Outperform	$40.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
8/22/2016	Bank of America	Set Price Target	Buy	$40.00	N/A	i Rating by colin bristow at Bank of America Co.
8/22/2016	Credit Suisse Group	Reiterated Rating	Outperform	$40.00	N/A	i
8/18/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$44.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
8/3/2016	JPMorgan Chase & Co.	Set Price Target	Buy	$40.00	N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
8/3/2016	Citigroup	Reiterated Rating	Neutral	$37.00	N/A	i
8/2/2016	Barclays	Reiterated Rating	Equal Weight	$34.00	N/A	i
8/2/2016	Sanford C. Bernstein	Set Price Target	Buy	$38.00	N/A	i Rating by Tim Anderson at Sanford C. Bernstein
8/1/2016	Jefferies Financial Group	Set Price Target	Buy	$41.50 ➝ $40.00	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
7/25/2016	Piper Jaffray Companies	Set Price Target	Buy	$54.00	N/A	i Rating by Richard Purkiss at Piper Jaffray Companies
7/25/2016	JPMorgan Chase & Co.	Set Price Target	Buy	$40.00	N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
7/21/2016	BMO Capital Markets	Reiterated Rating	Buy	$40.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
7/14/2016	Jefferies Financial Group	Set Price Target	Buy	$40.00 ➝ $41.50	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
6/27/2016	Piper Jaffray Companies	Reiterated Rating	Overweight	$54.00	N/A	i
6/20/2016	Jefferies Financial Group	Lower Price Target	Buy	$42.00 ➝ $40.00	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
6/15/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy		N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
6/14/2016	Jefferies Financial Group	Reiterated Rating	Buy	$41.00 ➝ $42.00	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
5/19/2016	JPMorgan Chase & Co.	Reiterated Rating	Overweight		N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
5/17/2016	Morgan Stanley	Reiterated Rating	Hold	$36.00	N/A	i Rating by David Risinger at Morgan Stanley
5/12/2016	Berenberg Bank	Initiated Coverage	Hold	$38.00	N/A	i
5/11/2016	Jefferies Financial Group	Set Price Target	Buy	$41.00	N/A	i Rating by Jeffrey Holford at Jefferies Financial Group Inc.
5/10/2016	Bank of America	Reiterated Rating	Buy	$38.48 ➝ $28.25	N/A	i Rating by Colin Bristow at Bank of America Co.
5/10/2016	UBS Group	Set Price Target	Buy	$38.00	N/A	i Rating by Steven Milunovich at UBS Group AG
5/9/2016	The Goldman Sachs Group	Set Price Target	Neutral	$37.00	N/A	i
5/9/2016	Morgan Stanley	Set Price Target	Neutral	$36.00	N/A	i Rating by David Risinger at Morgan Stanley
5/9/2016	Credit Suisse Group	Boost Price Target	Outperform	$38.00 ➝ $39.00	N/A	i
5/4/2016	BMO Capital Markets	Reiterated Rating	Buy	$39.00 ➝ $40.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
5/4/2016	UBS Group	Boost Price Target	Buy	$36.00 ➝ $38.00	N/A	i
5/4/2016	Independent Research	Set Price Target	Neutral	$37.00	N/A	i
5/4/2016	Societe Generale	Set Price Target	Neutral	$34.00	N/A	i
5/3/2016	Sanford C. Bernstein	Set Price Target	Buy	$36.00	N/A	i Rating by Tim Anderson at Sanford C. Bernstein
5/2/2016	SVB Leerink	Lower Price Target	Market Perform	$37.00 ➝ $34.70	N/A	i Rating by Jason Gerberry at SVB Leerink LLC
4/28/2016	BMO Capital Markets	Reiterated Rating	Buy		N/A	i
4/18/2016	The Goldman Sachs Group	Reiterated Rating	Neutral	$35.00	N/A	i
4/12/2016	S&P Equity Research	Reiterated Rating	Buy		N/A	i Rating by Jeffrey Loo at S&P Equity Research
4/7/2016	Independent Research	Set Price Target	Neutral	$35.00	N/A	i
4/7/2016	Morgan Stanley	Initiated Coverage	Overweight ➝ Equal Weight	$35.00	N/A	i
4/7/2016	JPMorgan Chase & Co.	Initiated Coverage	Overweight	$38.00	N/A	i
4/6/2016	Societe Generale	Initiated Coverage	Hold	$33.00	N/A	i
4/5/2016	BMO Capital Markets	Reiterated Rating	Outperform	$39.00	N/A	i
4/5/2016	SVB Leerink	Reiterated Rating	Hold		N/A	i Rating by Jason Gerberry at SVB Leerink LLC
4/5/2016	Jefferies Financial Group	Reiterated Rating	Buy	$42.00 ➝ $39.00	N/A	i
4/5/2016	Sanford C. Bernstein	Reiterated Rating	Buy	$36.00	N/A	i
3/20/2016	Piper Jaffray Companies	Reiterated Rating	Overweight	$54.00	N/A	i Rating by Richard Purkiss at Piper Jaffray Companies
3/8/2016	Jefferies Financial Group	Reiterated Rating	Buy	$45.00 ➝ $42.00	N/A	i
2/22/2016	Jefferies Financial Group	Lower Price Target	Buy	$45.00	N/A	i
2/16/2016	SunTrust Banks	Lower Price Target	Neutral	$37.00 ➝ $33.00	N/A	i Rating by John Boris at SunTrust Banks, Inc.
2/11/2016	Argus	Boost Price Target	Buy	$32.00 ➝ $39.00	N/A	i
2/10/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy		N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
2/9/2016	Bank of America	Upgrade	Buy ➝ Top Pick	$39.00	N/A	i
2/5/2016	Credit Suisse Group	Lower Price Target		$41.00 ➝ $38.00	N/A	i
2/5/2016	Piper Jaffray Companies	Reiterated Rating	Overweight	$23.00	N/A	i Rating by Richard Purkiss at Piper Jaffray Companies
2/3/2016	Independent Research	Set Price Target	Neutral	$34.00	N/A	i
2/3/2016	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$43.00 ➝ $41.00	N/A	i
2/3/2016	Sanford C. Bernstein	Lower Price Target	Outperform	$41.00 ➝ $36.00	N/A	i
2/3/2016	BMO Capital Markets	Reiterated Rating	Outperform	$41.00 ➝ $39.00	N/A	i
1/26/2016	Nord/LB	Reiterated Rating	Buy		N/A	i
1/15/2016	UBS Group	Set Price Target	Buy	$36.00	N/A	i

(Data available from 1/15/2016 forward)

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; a drug discovery collaboration with Sosei Group Corporation; and collaboration with LianBio. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Today's Range

Now: $36.75

$36.61

$36.96

50 Day Range

MA: $38.26

$36.53

$42.56

52 Week Range

Now: $36.75

$27.88

$43.08

Volume

30,271,992 shs

Average Volume

35,117,566 shs

Market Capitalization

$204.27 billion

P/E Ratio

14.58

Dividend Yield

4.12%

Beta

0.66

Frequently Asked Questions

What sell-side analysts currently cover shares of Pfizer?

The following Wall Street analysts have issued reports on Pfizer in the last twelve months: Atlantic Securities, Barclays PLC, Berenberg Bank, Cantor Fitzgerald, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Piper Sandler, Royal Bank of Canada, Sanford C. Bernstein, Standpoint Research, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist, UBS Group AG, and Zacks Investment Research.

What is the current price target for Pfizer?

14 Wall Street analysts have set twelve-month price targets for Pfizer in the last year. Their average twelve-month price target is $40.07, suggesting a possible upside of 9.0%. Cantor Fitzgerald has the highest price target set, predicting PFE will reach $53.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $24.00 for Pfizer in the next year.

What is the current consensus analyst rating for Pfizer?

Pfizer currently has 10 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PFE, but not buy more shares or sell existing shares.

What other companies compete with Pfizer?

Other companies that are similar to Pfizer include Johnson & Johnson, Merck & Co., Inc., AbbVie, Eli Lilly and, Bristol-Myers Squibb, Zoetis, Royalty Pharma, Horizon Therapeutics Public, Jazz Pharmaceuticals, Perrigo, Pacira BioSciences, Corcept Therapeutics, Nektar Therapeutics, Endo International and Supernus Pharmaceuticals.

How do I contact Pfizer's investor relations team?

Pfizer's physical mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company's listed phone number is 212-733-2323. The official website for Pfizer is www.pfizer.com.

NYSE:PFE - Pfizer Stock Price Target and Predictions

Analyst Price Target for PFE

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Pfizer?

What is the current price target for Pfizer?

What is the current consensus analyst rating for Pfizer?

What other companies compete with Pfizer?

How do I contact Pfizer's investor relations team?